Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
39.45 USD | +1.75% | +4.60% | -22.18% |
May. 31 | Ionis Reports 'Positive Results' From Studies of Investigational Treatment for Hereditary Angioedema | MT |
May. 31 | Transcript : Ionis Pharmaceuticals, Inc. - Special Call |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-22.18% | 5.65B | |
+45.06% | 56.65B | |
-7.31% | 39.44B | |
+39.19% | 39.03B | |
-6.65% | 26.86B | |
+12.02% | 26.75B | |
-21.82% | 19.03B | |
+1.39% | 12.28B | |
+23.54% | 12.26B | |
+27.09% | 12.04B |
- Stock Market
- Equities
- IONS Stock
- News Ionis Pharmaceuticals, Inc.
- Earnings Flash (IONS) IONIS PHARMACEUTICALS Posts Q1 Revenue $119M